Home/ Supplements/ Vitamin K/ The Artery Pill

The Artery Pill

product on market Softgel Capsule Purity Products Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

Vitamin D and K2 are researched for their roles in supporting bone health and calcium regulation. However, the overall evidence coverage for this specific ingredient profile is very limited. These nutrients generally maintain systemic homeostasis when taken within recommended daily limits.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for The Artery Pill
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Softgel(s)
Serving Size
30
Servings
Fat/Fatty Acid
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
20 Calorie(s)
Total Fat
2 Gram(s) (3% DV)
Cholesterol
5 mg (2% DV)
25 mcg (125% DV)
1.7× RDA — within safe limits 608 studies (A:16, B:251)
180 mcg (150% DV)
1.5× RDA — within safe limits 275 studies (A:9, B:175)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

highly refined and concentrated Omega-3 Fish Oil Capsule Shell MenaQ7 Proprietary LemonLock Freshness System Cholecalciferol
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: Adults take 2 soft gels daily with a meal. For daily use.

Warnings & Precautions

Contains fish: (anchovy, sardine, mackerel) and soy.

Warning: This product contains vitamin K, which interferes with anticoagulants such as coumadin and warfarin. Do not take if taking anticoagulant medications.

Formulation Notes

Arterial support formula with omega-3 fish oil, vitamin K2 & vitamin D

Supports cardio health Helps maintain healthy arteries

1 gram EPA/DHA + vitamin K2

Additional Information

Intelligent nutritional solutions

Premium grade supplements Since 1993

Metadata

Product Details

DSLD Entry Date2021-03-25
Product TypeFat/Fatty Acid
FormSoftgel Capsule
BrandPurity Products
DSLD ID244180
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

Vitamin K-2
GNC Preventive Nutrition · Softgel Capsule
100
Vitamin K-2
NewtonEverett · Softgel Capsule
100
Low-Dose Vitamin K2 45 mcg
Life Extension · Softgel Capsule
100
Natural Vitamin K-2 Bioactive Form
Vitamin World · Softgel Capsule
100
Vitamin K2 50 mcg
Vitacost · Softgel Capsule
100
View all Vitamin K products →
Vitamin K research Best Vitamin K All Vitamin K products More from Purity Products View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.